At-Home Smell Test Can Help ID Risk for Cognitive Impairment
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 2, 2025 -- The digital remote AROMHA Brain Health Test (ABHT) can discriminate cognitively normal (CN) older adults from those with cognitive impairment, according to a study published online March 24 in Scientific Reports.
Benoît Jobin, Ph.D., from Massachusetts General Hospital in Boston, and colleagues developed the ABHT, an at-home odor identification, discrimination, memory, and intensity assessment, which was self-administered among 127 CN individuals (English and Spanish speaking), 34 participants with subjective cognitive complaints (SCC), and 19 participants with mild cognitive impairment (MCI). The test was self-administered remotely at home under unobserved (CN participants) and observed (CN, SCC, and MCI) modalities and in-person with a research assistant present (CN, SCC, and MCI).
The researchers found that with age, there was a decrease in odor memory, identification, and discrimination scores. In addition, compared with the CN and SCC groups, the MCI group had lower olfactory identification and discrimination, independent of age, sex, and education.
"These results suggest that the ABHT could be used in clinical research settings in different languages to explore the utility of olfactory biomarkers to predict the presence of blood-based, image-based, or cerebrospinal fluid-based biomarkers of neurodegenerative disease and longitudinal development of clinical symptoms," the authors write.
Several authors disclosed financial ties to Aromha.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
FRIDAY, Aug. 15, 2025 -- Opportunistic pop-up community screening identifies a high prevalence of uncontrolled cardiovascular risk factors, according to a study published online...
Missed Opportunity Common in Patients With High-Grade Serous Ovarian Cancer
FRIDAY, Aug. 15, 2025 -- A considerable proportion of patients with high-grade serous cancer (HGSC) have missed opportunities for risk assessment with genetic testing and for...
EHR Notes Reveal Potential Racial Bias in Doctors' Perception of Patient Credibility
FRIDAY, Aug. 15, 2025 -- An analysis of more than 13 million electronic health record (EHR) notes shows potential racial bias in how doctors document patient trustworthiness...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.